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Abstract
Background: Although it is established that opioid and Mycobacterium tuberculosis are both public health problems, the
mechanisms by which they affect lung functions remain elusive.
Methodology/Principal Findings: We report here that mice subjected to chronic morphine administration and M.
tuberculosis infection exhibited significant apoptosis in the lung in wild type mice as demonstrated by the terminal
deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling assay. Morphine and M. tuberculosis
significantly induced the expression of Toll-like receptor 9 (TLR9), a key mediator of innate immunity and inflammation.
Interestingly, deficiency in TLR9 significantly inhibited the morphine and M. tuberculosis induced apoptosis in the lung. In
addition, chronic morphine treatment and M. tuberculosis infection enhanced the levels of cytokines (TNF-a, IL-1b, and IL-6)
in wild type mice, but not in TLR9 knockout (KO) mice. The bacterial load was much lower in TLR9 KO mice compared with
that in wild type mice following morphine and M. tuberculosis treatment. Morphine alone did not alter the bacterial load in
either wild type or TLR9 KO mice. Moreover, administration of morphine and M. tuberculosis decreased the levels of
phosphorylation of Akt and GSK3b in the wild type mice, but not in TLR9 KO mice, suggesting an involvement of Akt/GSK3b
in morphine and M. tuberculosis-mediated TLR9 signaling. Furthermore, administration of morphine and M. tuberculosis
caused a dramatic decrease in Bcl-2 level but increase in Bax level in wild type mice, but not in TLR9 KO mice, indicating a
role of Bcl-2 family in TLR9-mediated apoptosis in the lung following morphine and M. tuberculosis administration.
Conclusions/Significance: These data reveal a role for TLR9 in the immune response to opioids during M. tuberculosis
infection.
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Introduction
Opioids have been widely applied in clinics as one of the most
potent pain relievers for centuries. However, opioids as clinical
therapies produce benefits as well as severe side effects. Studies
showed that opiates, including morphine, cause cell death and
apoptosis in various systems. We have previously reported that
opioids promote lymphocyte apoptosis both in vitro and in vivo
[1,2]. Recent studies have demonstrated that PI3K/Akt signaling
is required for opioid induced cell proliferation and the survival
signaling pathway with changes in intracellular proapoptotic
elements such as Bax, Hsp70 and antiapoptotic elements such as
Bcl-2 in response to morphine effects [3]. Apoptotic pathways
induced by opioids seem to be mediated by the mitochondrial
apoptotic pathway, associated with a decrease in Bcl-2 levels and
direct interference with the mitochondrial transmembrane poten-
tial [4]. The effects of opioids in various infections are well known
[5]. However, very little is known about the effect of opioids on
tuberculosis infection.
M. tuberculosis remains a leading global public health problem
despite the availability of chemotherapy and BCG vaccine [6]. A
few studies have shown that opioid addicts are more susceptible to
mycobacterial infections than non-addicts [7] and can also show
anergy towards tuberculin test, thus obscuring the diagnosis of TB
[8]. Macrophages infected with M. tuberculosis undergo increased
apoptosis, which is caspase-8 dependent but caspase-9 indepen-
dent [9].
Toll-like receptors (TLRs) play a critical role in both innate
resistance and the initiation of adaptive immunity to infectious
agents [10–13]. TLRs recognize pathogen-associated molecular
patterns (PAMPs) or endogenous inflammation-associated mole-
cules [10,14,15]. TLRs recognize distinct molecular structures on
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TLR3, TLR7, TLR8, and TLR9), different sets of TLRs have
been associated with the response to different classes of micro-
organisms [10–13]. Recent studies have suggested that stimulation
of TLRs can result in apoptosis by triggering pro-apoptotic
signaling [16]. TLR2 stimulation activates the phosphoinositide 3-
kinase (PI3K)/Akt signaling pathway [17]. Akt regulates cellular
activation, inflammatory response, and apoptosis. Activated Akt
phosphorylates several downstream targets of the PI3K signaling
pathway such as GSK3b. GSK3b is a constitutively active enzyme
that is inactivated by Akt [17,18]. GSK3b plays a pivotal role in
regulating many cellular functions, including cell survival and
apoptosis [17–19]. Available evidence suggests that TLR9
participates in the modulation of immune responses to TB [20].
Hoelscher et al. reported that TLR2/4/9-deficient mice con-
trolled M. tuberculosis replication [21], however, the role of TLR for
immune response to M. tuberculosis is still controversial [21]. Our
studies focus on the role of TLR9 in morphine administration and
M. tuberculosis infection, not only M. tuberculosis infection.
In this study, we show opioids through potent stimulus of
TLR9-dependent proinflammatory cytokine production caused
altered host resistance against M. tuberculosis in the mouse model.
In addition, our data demonstrate that mice deficient in TLR9
inhibit morphine-induced apoptosis during M. tuberculosis infection.
Finally, we found that inhibition of TLR9 prevents morphine and
M. tuberculosis -induced apoptosis through pro-apoptotic and anti-
apoptotic pathways. Taken together, these data reveal a role for
TLR9 in the immune response to opioids during M. tuberculosis
infection and provide an important example of TLR9 in host
resistance to infection.
Results and Discussion
A Deficiency in TLR9 Is Resistant to Morphine and
M. tuberculosis–Induced Apoptosis
We have recently reported that opioids induce lymphocyte
apoptosis [1,2,22,23]. We havealso shown that opioid promotes cell
apoptosisthroughTLR2 [16].However,the role ofTLRsinopioid-
mediated apoptosis during M. tuberculosis infection is unknown. It
has been shown that morphine increase the expression of TLR9
[24]. We therefore asked whether TLR9 is involved in morphine
additive effect with M. tuberculosis infection on inducing apoptosis.
During the mouse infection with M. tuberculosis H37Ra, we
implanted wild type mice and TLR9 knockout mice with a 25 mg
sustained-release morphine pellet, while control mice received a
comparableplacebopelletfordifferenttimeperiodsand determined
apoptotic cells using the TUNEL technique. We found that chronic
morphine administration or H37Ra infection alone induced cell
apoptosis in the lungs from wild type mice, but not in TLR9
deficient mice (Fig. 1A). Combination of morphine treatment and
H37Rainfectionhasa significantadditive effectonapoptosisinwild
type mice. Notably, a deficiency in TLR9 mice is resistant to this
additive effect. Therefore, morphine and M. tuberculosis-induced cell
apoptosis requires TLR9.
We next examined the level of TLR9 in the lungs with or
without morphine and H37Ra infection. As shown in Fig. 1 B, the
expression of TLR9 in the lungs was significantly enhanced after
morphine treatment and H37Ra infection as detected by
quantitative real time RT-PCR. These results suggest a prominent
role of morphine and H37Ra infection in the induction of TLR9
expression.
Figure 1. M. tuberculosis H37Ra and morphine cause apoptosis. Wild type and TLR9 KO male mice aged 9–10-week were i.p. injected with
2.5610
7 H37Ra bacteria in 100 ml. After 4 hours post-injection, mice were implanted subcutaneously with a 25 mg morphine base pellet and the
male mice with a placebo pellet implantation as controls as described under Materials and Methods. The lungs were sectioned and apoptotic cells
(dark brown color cells) were determined by TUNEL assay (A). Photographs of representative TUNEL-stained cells are shown at the top. Magnification
2006. The bar graph at the bottom shows the percentage of apoptotic cells (A). Results represent mean 6 S. E. M. of three independent experiments.
The lungs were also harvested for TLR9 expression by real-time quantitative RT-PCR in the wild type mice (B). Means and SEs were calculated from 5–
7 mice per group. * p,0.01 compared with wild type control group.
doi:10.1371/journal.pone.0009205.g001
TLR9-Mediated Apoptosis
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Levels in Wild Type Mice but Not in TLR9 Deficient Mice
It has been demonstrated that M. tuberculosis is a potent
stimulator of TLR9-dependent pro-inflammatory cytokine pro-
duction in macrophages [20]. Activation of TLRs stimulates the
production of inflammatory cytokines [25]. We determined
whether TLR9 plays a role in the inflammatory response following
morphine treatment and H37Ra infection. As shown in Fig. 2A,
either morphine or H37Ra alone induced inflammation with
hyperaemia in the lung in wild type mice, but not in TLR9
knockout mice. Of greater significance, a deficiency of TLR9 in
mice significantly attenuated morphine and H37Ra-induced
inflammation with hyperaemia.
We then examined the expression levels of proinflammatory
cytokines in TLR9 KO and wild type mice following morphine
administration and H37Ra infection. Administration of morphine
and M. tuberculosis dramatically increased the expression of TNF-a,
IL-1b, and IL-6 in the wild type mice. Interestingly, significantly
(2- to 3-fold) lower expression of IL-1b, and IL-6 was observed in
the TLR9 KO mice as compared with the wild type control mice
(Fig. 2B). These data suggest that a pro-inflammatory role for
TLR9 in morphine treatment and H37Ra-mediated immune
responses.
TLR9 Deficiency Prevents Morphine and M. tuberculosis
H37Ra-Decreased Phosphorylation of Akt and GSK3b
Growingevidence suggests that thereis a cross-talk between TLR
signaling and the PI3K/Akt signaling pathway [17,18]. Addition-
ally, the PI3K/Akt signaling pathway may be an endogenous
negative feedback regulator of TLR4-mediated immune responses.
Our previous studies showed that TLR2-mediated morphine
induced apoptosis through PI3K/Akt/GSK3b in neurons. In the
present study, to examine whether TLR9 can activate Akt signaling
following morphine and H37Ra infection in wild type mice and
TLR9 KO mice, we determined the levels of phosphorylated Akt
(phospho-Akt) at Ser
473. The levels of phospho-Akt at Ser
473 in the
lungs from wild type mice were significantly lower compared with
control (without treatment) wild type mice (Fig. 3A). Importantly,
reduced levels of phospho-Akt at Ser
473 caused by morphine and
H37Ra were inhibited in the lung from TLR9 KO mice (Fig. 3B).
These results suggest that morphine and H37Ra decrease Akt
activity through a TLR9-dependent mechanism.
GSK3b is an important downstream target of the Akt signaling
pathway [19]. Phosphorylation of GSK-3b on the inactivating
residue serine-9 by Akt results in GSK-3b inactivation [17,19]. We
investigated the effect of TLR9 on phosphorylation of GSK-3b
with or without morphine treatment and H37Ra infection. As
Figure 2. A deficiency in TLR9 is resistant to H37Ra and morphine-induced inflammatory responses. Wild type and TLR9 KO male mice
aged 9–10-week were i.p. injected H37Ra and implantation of morphine pellets and placebo pellets as in Fig. 1. (A) The lungs were fixed by formalin,
embedded with paraffin, and sectioned (10-mm-thick) and then stained with hematoxylin and eosin. Representative sections from wild type and TLR9
KO mice are shown. Magnification 1006. Data are representatives of at least three independent experiments. (B) The lungs were harvested as Fig. 1
and total RNA was isolated. The expression of TNF-a, IL-1b, and IL-6 was determined by real-time quantitative RT-PCR. The level of gene expression is
presented as relative mRNA expression units. Means and SEs were calculated from 5–7 mice per group. * p,0.01 compared with wild type control
group and H37Ra alone treatment group.
doi:10.1371/journal.pone.0009205.g002
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the levels of GSK3b serine-9 phosphorylation in the lungs from
the wild type mice, but not from TLR9 KO mice. Since
phosphorylation of serine-9 is inhibitory for GSK3b activity, these
data demonstrate that morphine and H37Ra decrease GSK3b
activity through a TLR9-dependent signaling pathway.
Effect of TLR9 on the Levels of Bcl-2 and Bax following
Morphine Administration and H37Ra Infection
Activated Akt induces the alteration of Bcl2 and Bax expression
and plays an antiapoptotic role in several different cell types [26]. It
has been demonstrated that TLR9 agonist CpG-DNA induces
phosphorylation of Bad, a pro-apoptotic member of the Bcl-2 family,
at Ser
112 and Ser
136 through activation of Akt [27]. Phosphorylated
Bad then dissociates from Mcl-1, allowing the expression of anti-
apoptotic effects [28]. Wedetermined the expression of pro-apoptotic
protein Bax and anti-apoptotic protein Bcl-2 after treatment of
morphine and H37Ra infection. Treatment of morphine with
R37Ra infection significantly decreased the levels of Bcl-2 (Fig. 4A)
and increased the levels of Bax (Fig. 4B) in the lung from wild type
mice. However, morphine with H37Ra did not alter the levelsof Bcl-
2 (Fig. 4A) and Bax (Fig. 4B) in the lung from TLR9 KOmice. Taken
together, our results suggest that Bcl-2 family is involved in TLR9-
mediated apoptosis in the lung following morphine and H37Ra
administration.
Deficiency in TLR9 Attenuates Morphine and H37Ra-
Induced Increase in Lung CFU Counts
To examine the effects of TLR9 on host resistance manifested by
changes in pulmonary bacterial load after morphine administration
and H37Ra infection, TLR9 KO mice and wild type mice were
chronically administered with morphine during H37Ra infection.
The CFU count in the lungs was determined by plating the lung
homogenates on 7H11 agar plates. As shown in Fig. 5, significantly
greater CFU count was observed in the lung tissues when wild type
mice were treated with both morphine and H37Ra than they were
treated with either morphine or H37Ra alone. Notably, morphine
and H37Ra-indcued increase in CFU count was significantly
inhibited in the lung tissues from the TLR9 KO mice, suggesting
that this additive effect requires TLR9. Singh et al. [29] have
suggested that morphine exerts a dose-dependent effect in murine
tuberculosis. Our data demonstrate a role of TLR9 in the immune
responses to opioids during M. tuberculosis infection and provide an
important example of TLR9 in host resistance to infection.
The studies presented here show that TLR9 deficient miceexhibit
distinct defects in immune response to opioids and M. tuberculosis in
vivo. Moreover, as discussed above, in several cases individual
immune deficiencies appeared to be linked to TLR9. For example,
morphine and H37Ra-induced TNF, IL-1, and IL-6 production
appears to be controlled by TLR9 (Fig. 2). The findings of this study
have several implications for the investigation of the role of TLRs in
susceptibility of humans to drug abuse and mycobacterial infections.
The involvement of these receptors has been suggested from genetic
studies correlating single nucleotide polymorphisms within the
TLR9 gene, with disease susceptibility to infection in populations
exposed to M. tuberculosis [30]. A limitation of the study is the use of
attenuated strain M. tuberculosis H37Ra. Virulent strains such as M.
tuberculosis H37Rv will be used in future studies.
An outbreak of multidrug-resistant tuberculosis at a methadone
treatment program has been identified recently [31], which under-
scores the emergency of developing effective strategies to prevent TB
transmission in such setting. Our findings presented here demon-
strate a critical role of TLR9 involved in the chronic morphine
administration induced impairment of pulmonary immune response
to murine tuberculosis infection. TLR9 is known to recognize
oligonucleotide derived from M. tuberculosis genome [31]. Further
studies are needed to determine the mechanisms by which opioid
administration may affect the immune system and the susceptibility
to mycobacterial infections.
Materials and Methods
Experimental Animals
TLR9KOmiceona Balb/cbackground werekindlyprovided by
Dr. Shizuo Akira (Osaka University, Osaka, Japan) via Dr. Dennis
Figure 3. Role of TLR9 in H37Ra and morphine-mediated Akt and GSK-3b phosphorylation. The lungs were harvested from wild type and
TLR9 KO mice after H37Ra and morphine administration as in Fig. 1. Total and p-Akt (A), total and p-GSK3b (B) were determined by Western blot.
Representative results of the level of p-Akt, total Akt, p-GSK3b and p-GSK3b are shown at the top of each pane. Means and SEs were calculated from 5
mice per group. * p,0.01 compared with wild type control group.
doi:10.1371/journal.pone.0009205.g003
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Balb/c mice were purchased from the Jackson Laboratory (Bar
Harbor, ME) and maintained in the Division of Laboratory Animal
Resources at East Tennessee State University (ETSU), a facility
accredited by the Association for the Assessment and Accreditation
of Laboratory Animal Care International (AAALAC). All aspects of
the animal care and experimental protocols were approved by the
ETSU Committee on Animal Care. Male mice aged 8 weeks were
used in all experiments.
Reagents
Placebo pellets and morphine pellets were kindly provided by
National Institutes of Drug Abuse (NIDA). The antibodies to total
Akt, phosphor-Akt (Ser 473), total GSK3b, phospho-GSK3b (Ser9)
were purchased from Cell Signaling Technology (Beverly, MA).
The antibodies to Bcl-2, Bax, and GAPDH were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). In situ apoptosis
detection kit was purchased from Roche Diagnostic (Indianapolis,
IN). The Quantitative PCR kit was purchased from Invitrogen
(Carlsbad, CA). M. tuberculosis strain H37Ra was grown in 7H9
liquid medium (Difco) supplemented with 0.05% Tween 80 and
10% BSA-dextrose-catalase (ADC) enrichment (Difco) at 37uC for
approximately 2 weeks with occasional agitation.
Experimental Protocol
Wide type and TLR9 KO mice were randomly divided into four
groups of 10 each respectively: control group (C), morphine group
(M), H37Ra group (H37Ra), and H37Ra with morphine group
(H37Ra + M). Each of the mice in H37Ra and M groups received
an intraperitoneal (i.p.) injection with 2.5610
7 bacteria in 100 ml
[29]. Each of the mice in C and M groups were i.p. injected with
100 ml PBS. After 4 hours injection, mice in M and H37Ra with M
group were anesthetized with inhaled isofluorane and implanted
subcutaneously with a 25 mg morphine base pellet and the male
mice with a placebo pellet implantation served as controls. Under
isoflurane anesthesia, a small skin pocket was dissected in the
animal’s back, where a single pellet was inserted and the skin was
closed with surgical sutures [32–34]. Fifteen days later, the second
implantations were performed. Another fifteen days after second
implantation, mice were sacrificed and the lungs were harvested.
Partial lungs were excised and frozen in liquid nitrogen for CFU
enumeration, gene and protein analysis. Partial lungs were
submerged in 4% paraformaldehyde in PBS, fixed with formalin
and embedded with paraffin. Other lungs were immediately frozen
by liquid nitrogen for molecular and cellular studies.
Figure 5. A deficiency in TLR9 is resistant to H37Ra and
morphine-induced lung CFU values. After H37Ra and morphine
administration, the lungs were harvested from wild type and TLR9 KO
mice and CFU counts were determined as described under Materials
and Methods. Data are from three independent experiments. Means
and SEs were calculated from 5 to 7 mice per group. * p,0.01
compared with control wild type group.
doi:10.1371/journal.pone.0009205.g005
Figure 4. Effect of TLR9 in H37Ra and morphine-mediated expression of Bcl-2 and Bax. We harvested lungs from wild type and TLR9 KO
mice following H37Ra and morphine administration as Fig. 1. The expression of Bcl-2 (A) and Bax (B) was examined by Western blot analysis.
Representative results of the levels of Bcl-2 and Bax are shown at the top of each pane. Means and SEs were calculated from 5 mice per group.
* p,0.01 compared with control wild type group.
doi:10.1371/journal.pone.0009205.g004
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The lungs were homogenized in 1 ml PBS buffer containing
0.1% Tween 80. The suspension was diluted in serial 10-fold
dilutions. Triplicate samples (50 ml) were plated on 7H11 plates
supplemented with ADC, and antibiotic cocktail (cycloheximide
10 mg/ml, carbenicillin 50 mg/ml, polymyxin B 25 mg/ml and
trimethoprim 20 mg/ml) to prevent contamination. The CFU
values were counted after 3 week incubation at 37uC.
Measurement of Cytokine Gene Expression in Lung
Tissues
Total RNA was isolated from lungs by the VERSA GENE
TM
RNA Tissue Kit (Gentra SYSTEMS; Minnesota) and the real-
time RT-PCR detection technique was performed as described
previously [23]. Briefly, first-strand cDNA was synthesized from
1 mg of total RNA using a Reaction Ready
TM first strand cDNA
synthesis kit (SABioscience Corporation, Frederick, MD). After
incubation at 70uC for 3 min and cooling down to 37uC for
10 min, RT cocktail was added to the annealing mixture and
further incubated at 37uC for 60 min. 2 ml of 1:2 diluted cDNA
was subjected to real-time quantitative PCR using Bio-Rad iCycler
iQ Multicolor Real-Time PCR Detection System (Bio-Rad Life
Science Research, Hercules, CA). PCR was performed in a 25 ml
volume using SYBR GreenER qPCR Super Mix for iCycler
(Invitrogen Corporation, Carlsland, CA). All primers were
purchased from SuperArray Bioscience Corporation. All PCR
assays were performed in triplicate. The following primer pairs
were used: for TLR9: CCCTGGTGTGGAACATCAT(forward)
and GTTGGACAGGTGGACGAAGT (reverse); TNF-a: AGT-
TCCCAAATGGCCTCCCTCTCA(forward) and TGGTTTG-
CTACGA CG-TGGGCTACA(reverse); IL-1b: CTGGAGAGT-
GTGGATCCCAAGCAA(forward) and GGGAACTC- TGCA-
GACTCAAACTCCAC(reverse); IL-6: AGCCAGAGTCCTTC-
AGAGAGATACAG(forward) and CTCCAGCTTATCTGTTA-
GGAGAGCA(reverse).
Detection of Apoptosis by TUNEL Assay
The frozen sections from wild type and TLR9 KO mice were
harvested for terminal deoxynucleotidyl transferase biotin-dUTP
nick end labeling (TUNEL) assay. Nucleosomal DNA fragmenta-
tion in cells was determined by the TUNEL assay using an in situ
apoptosis detection kit according to the manufacturer’s instruc-
tions and our previous publications [22,35]. The number of
apoptotic cells was counted in randomly selected fields to calculate
the ratio of apoptotic cells and total 500 cells.
Histopathology
Lungs were fixed by formalin, embedded with paraffin,
sectioned and then stained with hematoxylin and eosin.
Western Blot Analysis
Western blotting was performed as described in our previous
publications [35,36]. Briefly, protein concentration was measured
using the bicinchoninic acid kit according to the manufacturer’s
instructions. Equal amounts of protein were separated by 12%
SDS-PAGE then transferred to a nitrocellulose membrane (Bio-
Rad, Hercules, CA). The membrane was then incubated at room
temperature in a blocking solution composed of 5% skim milk
powder dissolved in 16TBS for 1 h. The membrane was then
incubated overnight at 4uC with the blocking solution containing
first antibody. After washing three times with TBS-T for 5 min,
the blot was incubated with a second antibody. The blot was again
washed three times with TBS-T before being exposed to the
SuperSignal West Dura Extended Duration substrate (Pierce
Biotechnology, Rockford, IL).
Statistical Analysis
All data were represented as means 6 SEM. Differences among
groups were compared by one-way analysis of variance (ANOVA)
followed by Tukey’s multiple-comparison test. P,0.05 was con-
sidered to be significant.
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